Three Cases of Erythema Multiforme Developed during Deflazacort Therapy in Children with Nephrotic Syndrome
Journal of the Korean Society of Pediatric Nephrology
; : 123-127, 2014.
Article
in English
| WPRIM (Western Pacific)
| ID: wpr-223753
Responsible library:
WPRO
ABSTRACT
Erythema multiforme (EM) is an acute mucocutaneous disorder involving the skin, mouth, eyes, and genital organs. It is classified into EM minor and EM major according to the involvement of the mucosal membrane. Stevens-Johnson syndrome (SJS) and toxic epidermal necrosis (TEN) belong to EM major. Compared to EM minor, SJS presents with more severe and progressive symptoms, and has a higher mortality rate. Corticosteroids are used in the treatment of EM. We report three cases of EM (two cases of EM minor and one case of SJS) that developed during treatment with oral corticosteroid (deflazacort; Calcort(R)) in children with nephrotic syndrome.
Full text:
Available
Health context:
SDG3 - Health and Well-Being
/
SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases
Health problem:
Target 3.2: Reduce avoidable death in newborns and children under 5
/
Chronic Kidney Disease
/
Skin Diseases
Database:
WPRIM (Western Pacific)
Main subject:
Skin
/
Mortality
/
Erythema Multiforme
/
Stevens-Johnson Syndrome
/
Adrenal Cortex Hormones
/
Genitalia
/
Membranes
/
Mouth
/
Necrosis
/
Nephrotic Syndrome
Type of study:
Prognostic study
Limits:
Child
/
Humans
Language:
English
Journal:
Journal of the Korean Society of Pediatric Nephrology
Year:
2014
Document type:
Article